dc.contributor.author |
Kopp, Hans-Georg |
|
dc.date.accessioned |
2020-09-09T14:17:41Z |
|
dc.date.available |
2020-09-09T14:17:41Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
1097-0215 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/106697 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Wiley |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1002/ijc.33025 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC) |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20200715072417_00513 |
|
utue.personen.roh |
Lorenzen, Sylvie |
|
utue.personen.roh |
Knorrenschild, Jorge Riera |
|
utue.personen.roh |
Pauligk, Claudia |
|
utue.personen.roh |
Hegewisch-Becker, Susanna |
|
utue.personen.roh |
Seraphin, Joerg |
|
utue.personen.roh |
Thuss-Patience, Peter |
|
utue.personen.roh |
Kopp, Hans-Georg |
|
utue.personen.roh |
Dechow, Tobias |
|
utue.personen.roh |
Vogel, Arndt |
|
utue.personen.roh |
Luley, Kim Barbara |
|
utue.personen.roh |
Pink, Daniel |
|
utue.personen.roh |
Stahl, Michael |
|
utue.personen.roh |
Kullmann, Frank |
|
utue.personen.roh |
Hebart, Holger |
|
utue.personen.roh |
Siveke, Jens |
|
utue.personen.roh |
Egger, Matthias |
|
utue.personen.roh |
Homann, Nils |
|
utue.personen.roh |
Probst, Stephan |
|
utue.personen.roh |
Goetze, Thorsten Oliver |
|
utue.personen.roh |
Al-Batran, Salah-Eddin |
|
dcterms.isPartOf.ZSTitelID |
International Journal of Cancer |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |